InsiderFlow

Venrock Healthcare Capital Partners III, L.P.

KALV

Venrock Healthcare Capital Partners III, L.P. serves as 10 percent owner at KalVista Pharmaceuticals, Inc. (KALV). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

14 trades

$20.84M

Total Sells

1 trades

$3.69M

Net Position

Net Buyer

$17.15M

Companies Traded

2

KALV, ORKA

Active Period

Dec 2023 – Mar 2026

15 total trades

Most Recent

Sell KALV

Mar 27, 2026 · $3.69M

Venrock Healthcare Capital Partners III, L.P.'s Insider Trading at KalVista Pharmaceuticals, Inc. (KALV)

Buys

13 · $19.44M

Sells

1 · $3.69M

Total Shares Bought

1,612,229

Total Shares Sold

214,631

KALV Price Chart
Loading chart...
DateTypeValue
Mar 27, 2026 Sell$3.69M
Apr 11, 2025 Buy$235.5K
Feb 14, 2025 Buy$1.50M
Feb 11, 2025 Buy$967.1K
Feb 3, 2025 Buy$621.6K
Feb 8, 2024 Buy$1.26M
Feb 1, 2024 Buy$1.27M
Jan 29, 2024 Buy$1.29M
Jan 24, 2024 Buy$1.24M
Jan 19, 2024 Buy$1.80M
Jan 16, 2024 Buy$333.8K
Jan 10, 2024 Buy$1.73M
Jan 5, 2024 Buy$720.5K
Dec 29, 2023 Buy$6.47M

Venrock Healthcare Capital Partners III, L.P.'s Insider Trading at Oruka Therapeutics, Inc. (ORKA)

Buys

1 · $1.41M

Sells

0 · $0.00

Total Shares Bought

122,882

Total Shares Sold

0

ORKA Price Chart
Loading chart...
DateTypeValue
Feb 27, 2025 Buy$1.41M